about
The role of surgery in advanced epithelial ovarian cancerMicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.Gallic acid, a phenolic compound, exerts anti-angiogenic effects via the PTEN/AKT/HIF-1α/VEGF signaling pathway in ovarian cancer cells.MicroRNA-298 inhibits malignant phenotypes of epithelial ovarian cancer by regulating the expression of EZH2.Reduced expression of SIRT2 in serous ovarian carcinoma promotes cell proliferation through disinhibition of CDK4 expression.miRNA-21 enhances chemoresistance to cisplatin in epithelial ovarian cancer by negatively regulating PTEN.
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Management of recurrent epithelial ovarian cancer.
@ast
Management of recurrent epithelial ovarian cancer.
@en
Management of recurrent epithelial ovarian cancer.
@nl
type
label
Management of recurrent epithelial ovarian cancer.
@ast
Management of recurrent epithelial ovarian cancer.
@en
Management of recurrent epithelial ovarian cancer.
@nl
prefLabel
Management of recurrent epithelial ovarian cancer.
@ast
Management of recurrent epithelial ovarian cancer.
@en
Management of recurrent epithelial ovarian cancer.
@nl
P2093
P2860
P1433
P1476
Management of recurrent epithelial ovarian cancer.
@en
P2093
Gustavo Acosta-Altamirano
Víctor Manuel Vargas-Aguilar
Víctor Manuel Vargas-Hernández
P2860
P304
P356
10.3978/J.ISSN.2227-684X.2013.10.01
P577
2014-08-01T00:00:00Z